Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Omae

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Geroscience|July 29, 2025
Health-related quality of life trajectories and loss of independence among community-dwelling older adultsAtsushi Takayama, Kenji Omae, Takeshima Taro, et al.
BMC Nephrology|April 7, 2019
Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients; a cross-sectional studyMai Tanaka, Hiroki Nishiwaki, Hiroshi Kado, et al.
Clinical Genitourinary Cancer|May 13, 2017
Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching StudyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Urologic Oncology|June 17, 2017
Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 10, 2017
Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-Metastatic Renal Cancer in Long-Term Dialysis PatientsKenji Omae, Tsunenori Kondo, Toshio Takagi, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 3, 2016
Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four casesKenji Omae, Tsunenori Kondo, Toshio Takagi, et al.
Oncotarget|October 6, 2017
Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysisKenji Omae, Yasushi Tsujimoto, Michitaka Honda, et al.
BMC Cancer|October 26, 2019
Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigationKenji Omae, Yuki Kataoka, Yasushi Tsujimoto, et al.
BJU International|June 16, 2015
Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching studyToshio Takagi, Tsunenori Kondo, Junpei Iizuka, et al.
Annals of Surgical Oncology|June 15, 2019
Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase ConcentrationsMitsuro Kanda, Masahiko Koike, Chie Tanaka, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Geroscience|July 29, 2025
Health-related quality of life trajectories and loss of independence among community-dwelling older adultsAtsushi Takayama, Kenji Omae, Takeshima Taro, et al.
BMC Nephrology|April 7, 2019
Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients; a cross-sectional studyMai Tanaka, Hiroki Nishiwaki, Hiroshi Kado, et al.
Clinical Genitourinary Cancer|May 13, 2017
Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching StudyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Urologic Oncology|June 17, 2017
Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 10, 2017
Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-Metastatic Renal Cancer in Long-Term Dialysis PatientsKenji Omae, Tsunenori Kondo, Toshio Takagi, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 3, 2016
Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four casesKenji Omae, Tsunenori Kondo, Toshio Takagi, et al.
Oncotarget|October 6, 2017
Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysisKenji Omae, Yasushi Tsujimoto, Michitaka Honda, et al.
BMC Cancer|October 26, 2019
Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigationKenji Omae, Yuki Kataoka, Yasushi Tsujimoto, et al.
BJU International|June 16, 2015
Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching studyToshio Takagi, Tsunenori Kondo, Junpei Iizuka, et al.
Annals of Surgical Oncology|June 15, 2019
Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase ConcentrationsMitsuro Kanda, Masahiko Koike, Chie Tanaka, et al.
Pageof 11